Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Elizabeth McFarland

Concepts (385)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
50
2026
3017
3.150
Why?
HIV-1
27
2026
895
2.840
Why?
Respiratory Syncytial Virus Vaccines
6
2022
38
2.290
Why?
HIV Antibodies
13
2026
62
2.230
Why?
Respiratory Syncytial Virus Infections
6
2022
130
2.110
Why?
Respiratory Syncytial Virus, Human
6
2022
76
2.100
Why?
Infectious Disease Transmission, Vertical
18
2025
186
2.060
Why?
Anti-Retroviral Agents
12
2023
245
1.690
Why?
Anti-HIV Agents
13
2026
859
1.530
Why?
Viral Proteins
3
2020
369
1.510
Why?
Antibodies, Neutralizing
9
2026
305
1.110
Why?
Antibodies, Viral
8
2022
653
1.100
Why?
Colonography, Computed Tomographic
3
2024
8
0.950
Why?
Antibodies, Monoclonal
6
2025
1448
0.840
Why?
AIDS Vaccines
8
2018
53
0.840
Why?
Pre-Exposure Prophylaxis
1
2025
239
0.780
Why?
Pregnancy Complications, Infectious
8
2016
406
0.740
Why?
Gene Deletion
2
2020
388
0.710
Why?
Breast Feeding
4
2025
444
0.630
Why?
Atazanavir Sulfate
2
2017
44
0.620
Why?
HIV Protease Inhibitors
2
2017
68
0.610
Why?
Ritonavir
2
2017
75
0.600
Why?
Infant, Newborn
24
2026
6275
0.580
Why?
HIV Envelope Protein gp120
6
2017
61
0.570
Why?
Vaccines, Attenuated
6
2022
130
0.560
Why?
Vaccination
6
2020
1467
0.550
Why?
Incidental Findings
1
2018
80
0.540
Why?
Infant
32
2026
9818
0.510
Why?
Telemedicine
1
2025
891
0.500
Why?
Nelfinavir
1
2016
9
0.500
Why?
Radiation Dosage
1
2018
191
0.500
Why?
Lopinavir
1
2016
31
0.490
Why?
Syncope
1
2016
56
0.480
Why?
Bradycardia
1
2016
52
0.480
Why?
Patient Dropouts
1
2016
65
0.480
Why?
Lyme Disease
1
2016
61
0.470
Why?
Health Resources
1
2016
129
0.450
Why?
Infant, Newborn, Diseases
1
2016
113
0.440
Why?
HIV
5
2014
250
0.410
Why?
Patient Compliance
2
2018
610
0.380
Why?
Humans
76
2026
141187
0.380
Why?
Immunogenicity, Vaccine
4
2021
34
0.380
Why?
Referral and Consultation
1
2018
798
0.370
Why?
Child
37
2025
22308
0.370
Why?
Female
50
2026
75515
0.370
Why?
T-Lymphocytes, Cytotoxic
4
2005
174
0.350
Why?
CD4-Positive T-Lymphocytes
2
2017
1110
0.350
Why?
Virus Replication
4
2020
532
0.340
Why?
Adolescent
28
2025
22007
0.340
Why?
Male
41
2026
69783
0.330
Why?
Lymphocyte Activation
5
2017
1150
0.310
Why?
Young Adult
14
2026
13673
0.290
Why?
Viral Load
9
2017
506
0.270
Why?
HIV Seropositivity
2
2023
127
0.270
Why?
Bone Density
2
2025
494
0.270
Why?
Double-Blind Method
3
2020
1983
0.260
Why?
RNA, Viral
8
2023
693
0.250
Why?
Antibodies, Bacterial
2
2018
146
0.240
Why?
Dyslipidemias
2
2017
175
0.230
Why?
Bone Development
1
2025
54
0.230
Why?
Antiretroviral Therapy, Highly Active
6
2017
285
0.230
Why?
Immunoenzyme Techniques
1
2005
209
0.220
Why?
Immunoglobulin G
3
2022
900
0.220
Why?
Diverticulum
1
2024
12
0.210
Why?
Viremia
3
2011
150
0.210
Why?
Gene Products, gag
2
1994
38
0.210
Why?
Mammography
1
2025
159
0.200
Why?
Child, Preschool
21
2022
11457
0.200
Why?
Squalene
3
2017
7
0.200
Why?
Pregnancy
11
2023
7070
0.190
Why?
Complementarity Determining Regions
1
2002
51
0.190
Why?
Prospective Studies
5
2025
7739
0.190
Why?
Drug Resistance, Viral
2
2016
120
0.180
Why?
CD4 Lymphocyte Count
4
2017
284
0.180
Why?
Half-Life
1
2021
146
0.180
Why?
Growth Differentiation Factor 15
1
2021
40
0.180
Why?
Feasibility Studies
1
2025
1018
0.180
Why?
Mitochondrial Diseases
1
2021
94
0.170
Why?
Immunization Schedule
2
2018
203
0.170
Why?
Colorado
4
2025
4610
0.170
Why?
Drug Therapy, Combination
4
2017
1040
0.170
Why?
Receptors, Antigen, T-Cell, alpha-beta
1
2002
335
0.170
Why?
RNA, Small Untranslated
1
2020
12
0.170
Why?
Fibroblast Growth Factors
1
2021
180
0.170
Why?
T-Lymphocytes
2
2009
2002
0.160
Why?
env Gene Products, Human Immunodeficiency Virus
2
2017
16
0.160
Why?
Pilot Projects
1
2025
1820
0.160
Why?
Hydrophobic and Hydrophilic Interactions
1
2020
188
0.160
Why?
Cytokines
2
2021
2098
0.150
Why?
Point Mutation
1
2020
237
0.150
Why?
Body Temperature
1
2020
224
0.150
Why?
Haemophilus Vaccines
2
2018
30
0.150
Why?
Immunocompromised Host
2
2000
203
0.150
Why?
Immunologic Memory
2
2021
360
0.150
Why?
Insulin Resistance
3
2019
1225
0.150
Why?
Darunavir
1
2017
19
0.140
Why?
Interleukin-12
1
1998
123
0.140
Why?
Metabolic Syndrome
1
2021
349
0.140
Why?
CD8-Positive T-Lymphocytes
2
2011
918
0.140
Why?
Mycobacterium Infections, Nontuberculous
2
2012
364
0.130
Why?
Therapeutic Equipoise
1
2017
2
0.130
Why?
Dose-Response Relationship, Drug
1
2021
2064
0.130
Why?
Interferon-gamma
5
2012
792
0.130
Why?
Lymphopoiesis
1
2017
26
0.130
Why?
Antibody Formation
1
2018
298
0.130
Why?
Immunoglobulin A
2
2017
214
0.130
Why?
Uganda
1
2017
87
0.130
Why?
Receptors, CCR5
1
2017
60
0.130
Why?
High-Throughput Screening Assays
1
2018
157
0.130
Why?
CD4-CD8 Ratio
1
2016
24
0.130
Why?
HIV-Associated Lipodystrophy Syndrome
1
2016
11
0.130
Why?
Adult
16
2026
39177
0.120
Why?
Adoption
1
2016
30
0.120
Why?
Virus Latency
1
2016
80
0.120
Why?
Cohort Studies
8
2025
5799
0.120
Why?
Mothers
3
2017
785
0.120
Why?
Early Diagnosis
1
2016
244
0.110
Why?
Chickenpox Vaccine
1
2015
74
0.110
Why?
Continuity of Patient Care
1
2018
287
0.110
Why?
Body Height
2
2017
196
0.110
Why?
Zimbabwe
2
2025
61
0.110
Why?
Gene Products, env
1
1994
6
0.110
Why?
Disease Susceptibility
1
2017
352
0.110
Why?
Haemophilus influenzae type b
1
2014
12
0.110
Why?
Chickenpox
1
2015
81
0.110
Why?
Bacterial Capsules
1
2014
31
0.110
Why?
Antibody Affinity
1
2014
60
0.110
Why?
Acquired Immunodeficiency Syndrome
2
2000
235
0.110
Why?
Cote d'Ivoire
2
2025
9
0.110
Why?
Parotitis
1
2014
6
0.110
Why?
Vaccines, Synthetic
4
2005
139
0.110
Why?
South Africa
2
2025
240
0.110
Why?
Developing Countries
1
2016
317
0.100
Why?
Cytotoxicity, Immunologic
3
2002
226
0.100
Why?
Puberty, Delayed
1
2013
9
0.100
Why?
Intestines
1
2017
357
0.100
Why?
Leukocytes, Mononuclear
4
2013
573
0.100
Why?
RNA-Directed DNA Polymerase
1
1993
34
0.100
Why?
Mycobacterium chelonae
1
1993
9
0.100
Why?
Vaccines
1
2018
406
0.100
Why?
Lipids
1
2017
689
0.100
Why?
Patient Selection
1
2017
688
0.100
Why?
Retrospective Studies
8
2023
16273
0.100
Why?
Lamivudine
3
2023
65
0.100
Why?
Colorectal Neoplasms
1
2020
802
0.090
Why?
Breast Neoplasms
1
2025
2250
0.090
Why?
Mitochondria
2
2021
967
0.090
Why?
Cell Movement
1
2017
990
0.090
Why?
Cardiovascular Diseases
2
2016
2087
0.090
Why?
Pediatric Obesity
1
2019
600
0.090
Why?
STAT1 Transcription Factor
1
2012
71
0.090
Why?
Clinical Trials as Topic
1
2017
1052
0.090
Why?
Child Development
1
2017
498
0.090
Why?
Body Fat Distribution
1
2011
48
0.090
Why?
Polysorbates
3
2017
41
0.090
Why?
Body Weight
2
2017
996
0.090
Why?
Mycobacterium avium Complex
1
2012
87
0.090
Why?
Epitopes
2
2022
477
0.090
Why?
Cost-Benefit Analysis
2
2025
618
0.090
Why?
United States
9
2023
15220
0.080
Why?
Research Design
1
2017
1143
0.080
Why?
Biomedical Research
1
2017
703
0.080
Why?
Interleukin-2
2
2003
453
0.080
Why?
Respiratory Tract Infections
1
2014
385
0.080
Why?
Exercise
1
2021
2103
0.080
Why?
Freezing
1
2009
88
0.070
Why?
Prenatal Exposure Delayed Effects
1
2016
662
0.070
Why?
Absorptiometry, Photon
2
2025
266
0.070
Why?
Blood
1
2009
113
0.070
Why?
Algorithms
1
2016
1763
0.070
Why?
Phenotype
1
2017
3166
0.070
Why?
Staff Development
1
2009
60
0.070
Why?
Age Factors
4
2019
3292
0.070
Why?
T-Lymphocyte Subsets
2
2002
415
0.070
Why?
Biomarkers
4
2021
4174
0.070
Why?
Lymphocyte Subsets
2
2009
88
0.070
Why?
Enzyme-Linked Immunosorbent Assay
2
2021
855
0.070
Why?
Longitudinal Studies
3
2025
2902
0.070
Why?
Specimen Handling
1
2009
182
0.070
Why?
Enterovirus A, Human
1
2007
13
0.070
Why?
Faculty
1
2009
154
0.070
Why?
Withholding Treatment
1
2008
78
0.070
Why?
Adipose Tissue
1
2011
647
0.070
Why?
Central Nervous System Viral Diseases
1
2007
77
0.060
Why?
Polymerase Chain Reaction
4
2011
1056
0.060
Why?
DNA, Viral
2
2000
366
0.060
Why?
Flow Cytometry
3
2009
1197
0.060
Why?
Academic Medical Centers
1
2009
528
0.060
Why?
False Negative Reactions
1
2025
61
0.060
Why?
Isoantigens
1
1984
17
0.060
Why?
Enterovirus Infections
1
2007
172
0.060
Why?
Cell Line
3
2012
2885
0.060
Why?
Medical Audit
1
2025
78
0.060
Why?
C-Reactive Protein
2
2021
418
0.060
Why?
Immunity, Cellular
1
2006
269
0.050
Why?
Linear Models
2
2020
857
0.050
Why?
Follow-Up Studies
3
2021
5200
0.050
Why?
Disease Outbreaks
1
2007
419
0.050
Why?
Confusion
1
2024
30
0.050
Why?
Sequence Analysis, DNA
2
2007
824
0.050
Why?
Comorbidity
2
2021
1662
0.050
Why?
Thymus Gland
1
1984
319
0.050
Why?
Tablets
1
2023
41
0.050
Why?
Constriction, Pathologic
1
2024
238
0.050
Why?
Regression Analysis
2
2021
1020
0.050
Why?
Risk Factors
4
2021
10438
0.050
Why?
Respiratory Syncytial Viruses
1
2022
58
0.050
Why?
Genes, T-Cell Receptor beta
1
2002
23
0.050
Why?
Immunophenotyping
2
1994
329
0.050
Why?
Zidovudine
2
2015
79
0.050
Why?
Clone Cells
1
2002
266
0.050
Why?
Dose-Response Relationship, Immunologic
1
2001
85
0.050
Why?
Cough
1
2022
129
0.040
Why?
Vaccines, Subunit
1
2001
50
0.040
Why?
Emtricitabine
1
2023
205
0.040
Why?
Pyridones
1
2023
176
0.040
Why?
Clinical Trials, Phase I as Topic
1
2021
51
0.040
Why?
Tenofovir
1
2023
276
0.040
Why?
Ganciclovir
1
2000
53
0.040
Why?
Lung
1
2014
4134
0.040
Why?
Public Health Surveillance
1
2021
84
0.040
Why?
Computer Simulation
1
2005
1015
0.040
Why?
Africa
1
2020
119
0.040
Why?
Injections, Subcutaneous
1
2020
165
0.040
Why?
Adjuvants, Immunologic
2
2017
238
0.040
Why?
Diagnostic Tests, Routine
1
2021
110
0.040
Why?
Symptom Assessment
1
2021
129
0.040
Why?
Sex Factors
2
2019
2058
0.040
Why?
Cross-Sectional Studies
3
2021
5636
0.040
Why?
HIV Seronegativity
1
2019
30
0.040
Why?
HLA-D Antigens
1
1999
32
0.040
Why?
Risk
1
2021
904
0.040
Why?
Cytomegalovirus Infections
1
2000
197
0.040
Why?
Case-Control Studies
2
2019
3588
0.040
Why?
Prevalence
2
2016
2772
0.040
Why?
Cholesterol, HDL
1
2019
196
0.040
Why?
Lymphocyte Culture Test, Mixed
1
1998
51
0.040
Why?
Cytotoxicity Tests, Immunologic
1
1998
38
0.040
Why?
Diphtheria-Tetanus-Pertussis Vaccine
1
2018
27
0.040
Why?
Vaccines, Combined
1
2018
49
0.040
Why?
Hospitals
1
2023
696
0.040
Why?
Poliovirus Vaccine, Inactivated
1
2018
28
0.040
Why?
Amino Acid Sequence
1
2002
2158
0.040
Why?
Odds Ratio
1
2021
1052
0.040
Why?
Hepatitis B Vaccines
1
2018
43
0.040
Why?
Mutation
3
2018
4013
0.030
Why?
Drug Resistance, Microbial
2
2000
65
0.030
Why?
Molecular Sequence Data
1
2002
2929
0.030
Why?
Colon
1
2020
300
0.030
Why?
Nutrition Surveys
1
2019
273
0.030
Why?
Case Management
1
2018
67
0.030
Why?
Antigens, Viral
1
1998
179
0.030
Why?
Cholesterol
1
2019
405
0.030
Why?
Cholesterol, LDL
1
2019
361
0.030
Why?
Epitopes, T-Lymphocyte
1
1998
184
0.030
Why?
Immune Tolerance
1
1999
368
0.030
Why?
Treatment Adherence and Compliance
1
2017
27
0.030
Why?
Triglycerides
1
2019
514
0.030
Why?
Disease Management
1
2021
633
0.030
Why?
Reproducibility of Results
1
2005
3348
0.030
Why?
Lymphocyte Count
2
2009
167
0.030
Why?
Cell Division
1
1998
798
0.030
Why?
Uncertainty
1
2017
138
0.030
Why?
Treatment Failure
1
2017
354
0.030
Why?
Multicenter Studies as Topic
1
2017
338
0.030
Why?
Nevirapine
1
2015
18
0.030
Why?
Seroepidemiologic Studies
1
2015
166
0.030
Why?
Patient Outcome Assessment
1
2016
131
0.030
Why?
Genes, pol
1
1994
7
0.030
Why?
Time-to-Treatment
1
2017
217
0.030
Why?
Malnutrition
1
2016
85
0.030
Why?
Maternal Exposure
1
2017
202
0.030
Why?
Coinfection
1
2016
137
0.030
Why?
Antiviral Agents
1
2000
747
0.030
Why?
Randomized Controlled Trials as Topic
1
2021
1556
0.030
Why?
Vaccines, Conjugate
1
2014
64
0.030
Why?
Counseling
1
2018
398
0.030
Why?
Neutropenia
1
2015
157
0.030
Why?
Treatment Outcome
2
2021
11120
0.030
Why?
Cells, Cultured
2
2008
4208
0.030
Why?
Sexual and Gender Minorities
1
2018
234
0.030
Why?
Global Health
1
2017
386
0.030
Why?
Anemia
1
2015
177
0.030
Why?
Maternal-Fetal Exchange
1
2014
172
0.030
Why?
Electron Transport Complex IV
1
2013
62
0.030
Why?
Electron Transport Complex I
1
2013
42
0.030
Why?
Tuberculosis, Cutaneous
1
1993
3
0.020
Why?
Thrombocytopenia
1
2015
208
0.020
Why?
HIV Reverse Transcriptase
1
1993
31
0.020
Why?
CD8 Antigens
1
1993
75
0.020
Why?
Radiography, Thoracic
1
2014
178
0.020
Why?
Medication Adherence
1
2017
513
0.020
Why?
Severity of Illness Index
1
2021
2892
0.020
Why?
CD3 Complex
1
1993
106
0.020
Why?
Drug Administration Schedule
2
2008
771
0.020
Why?
Blood Pressure
1
2019
1748
0.020
Why?
Oxidative Phosphorylation
1
2013
200
0.020
Why?
Lymphocytes
1
1994
398
0.020
Why?
DNA, Mitochondrial
1
2013
211
0.020
Why?
P-Selectin
1
2011
28
0.020
Why?
E-Selectin
1
2011
57
0.020
Why?
Heteroduplex Analysis
1
2011
1
0.020
Why?
Tuberculosis, Pulmonary
1
1993
142
0.020
Why?
Pandemics
1
2020
1653
0.020
Why?
Antigens, CD
1
1994
539
0.020
Why?
Chemokine CCL2
1
2011
117
0.020
Why?
Blood Transfusion
1
1994
392
0.020
Why?
Hyperlipidemias
1
2011
125
0.020
Why?
Hospitalization
1
2021
2255
0.020
Why?
Cell Proliferation
2
2009
2504
0.020
Why?
Protein Multimerization
1
2012
194
0.020
Why?
Interferon-alpha
1
2012
196
0.020
Why?
Nontuberculous Mycobacteria
1
1993
205
0.020
Why?
Fibrinogen
1
2011
180
0.020
Why?
Cell Adhesion Molecules
1
2011
179
0.020
Why?
Healthcare Disparities
1
2017
666
0.020
Why?
Cross Infection
1
1993
254
0.020
Why?
Infant, Premature
1
1994
597
0.020
Why?
Pokeweed Mitogens
1
2009
7
0.020
Why?
Diagnosis, Differential
1
2014
1498
0.020
Why?
L-Selectin
1
2009
24
0.020
Why?
Human Experimentation
1
2009
14
0.020
Why?
Tetanus
1
2009
27
0.020
Why?
Leukocyte Common Antigens
1
2009
90
0.020
Why?
Candida
1
2009
41
0.020
Why?
Obesity
1
2021
3004
0.020
Why?
Multivariate Analysis
1
2011
1490
0.020
Why?
Meningitis, Aseptic
1
2007
13
0.020
Why?
Virus Cultivation
1
2007
31
0.020
Why?
Phosphorylation
1
2012
1768
0.020
Why?
Interleukin-6
1
2011
792
0.020
Why?
Cerebrospinal Fluid
1
2007
92
0.020
Why?
Data Interpretation, Statistical
1
2009
376
0.020
Why?
Paralysis
1
2007
70
0.020
Why?
Pregnancy Outcome
1
2010
457
0.020
Why?
Multiple Organ Failure
1
2007
127
0.020
Why?
B-Lymphocytes
1
2012
858
0.020
Why?
Kinetics
1
2010
1652
0.020
Why?
Genotype
1
2011
1859
0.020
Why?
Respiratory System
1
2007
157
0.020
Why?
Immunoglobulin A, Secretory
1
2005
9
0.020
Why?
Cell Survival
1
2009
1129
0.010
Why?
Phosphates
1
1987
181
0.010
Why?
Muscles
1
1987
333
0.010
Why?
Encephalitis
1
2007
137
0.010
Why?
Gastrointestinal Tract
1
2007
204
0.010
Why?
Mucous Membrane
1
2005
125
0.010
Why?
Chemistry, Physical
1
1984
38
0.010
Why?
Antigen-Antibody Reactions
1
1984
54
0.010
Why?
Chemical Phenomena
1
1984
82
0.010
Why?
DNA-Binding Proteins
1
2012
1478
0.010
Why?
Myasthenia Gravis
1
1984
23
0.010
Why?
Immunologic Deficiency Syndromes
1
1984
72
0.010
Why?
Saliva
1
2005
245
0.010
Why?
Tissue Distribution
1
1984
330
0.010
Why?
Tomography, X-Ray Computed
1
2014
2746
0.010
Why?
Epithelium
1
1984
316
0.010
Why?
Aging
2
2003
1892
0.010
Why?
Blood Glucose
1
2013
2269
0.010
Why?
Body Mass Index
1
2011
2382
0.010
Why?
Infusions, Intravenous
1
2003
417
0.010
Why?
Middle Aged
2
2020
34434
0.010
Why?
Anti-Bacterial Agents
1
1993
1865
0.010
Why?
Reference Values
1
2003
805
0.010
Why?
Mice, Inbred BALB C
1
1984
1274
0.010
Why?
Suspensions
1
2000
29
0.010
Why?
Capsules
1
2000
39
0.010
Why?
Urban Population
1
2003
485
0.010
Why?
Drug Tolerance
1
2000
105
0.010
Why?
Cytomegalovirus
1
2000
163
0.010
Why?
Signal Transduction
1
2012
5144
0.010
Why?
Administration, Oral
1
2000
803
0.010
Why?
Epithelial Cells
1
1984
1110
0.010
Why?
Immunization
1
2000
406
0.010
Why?
Time Factors
1
2008
6956
0.010
Why?
Recombinant Proteins
1
2000
1357
0.010
Why?
Macrophages
1
1984
1561
0.010
Why?
Tail
1
1987
29
0.000
Why?
Mice
1
1984
18048
0.000
Why?
Phosphocreatine
1
1987
45
0.000
Why?
Salamandridae
1
1987
33
0.000
Why?
Animals
2
1987
37657
0.000
Why?
Aged
1
1984
24574
0.000
Why?
Adenosine Triphosphate
1
1987
492
0.000
Why?
Magnetic Resonance Spectroscopy
1
1987
614
0.000
Why?
McFarland's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)